ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV) - ANVISA Registration 10269360448
Access comprehensive regulatory information for ANTIBODY FOR MULTIPLE HUMAN T-LYMPHOTROPIC VIRUSES (HTLV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10269360448 and manufactured by QUIBASA QUÍMICA BÁSICA LTDA. The registration is held by QUIBASA - QUIMICA BASICA LTDA with validity until Feb 05, 2034.
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ABBOTT GMBH, MP BIOMEDICALS ASIA PACIFIC PTE. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10269360448
25351442278202215
19400787000107
Company Information
Dates and Status
Feb 05, 2024
05/02/2034
09/18/2025 19:00:01
ANTICORPO PARA VÍRUS MÚLTIPLOS DE T-LINFOTRÓPICO HUMANO (HTLV)
Família Elecsys HTLV-I/II
Not specified
10287411667
Jul 31, 2023
ANTICORPO PARA VÍRUS MÚLTIPLOS DE T-LINFOTRÓPICO HUMANO (HTLV)
Família Elecsys HTLV-I/II
ROCHE DIAGNOSTICS GMBH
10287411667
Jul 31, 2023
ANTICORPO PARA VÍRUS MÚLTIPLOS DE T-LINFOTRÓPICO HUMANO (HTLV)
MAGLUMI HTLV I + II (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102512961
Feb 22, 2023
ANTICORPO PARA VÍRUS MÚLTIPLOS DE T-LINFOTRÓPICO HUMANO (HTLV)
MAGLUMI HTLV I + II (CLIA)
Not specified
80102512961
Feb 22, 2023
ANTICORPO PARA VÍRUS MÚLTIPLOS DE T-LINFOTRÓPICO HUMANO (HTLV)
HTLV I & II Ab ULTRA
Not specified
82532910030
Jan 02, 2023

